-
Kathryn E. McCollister, PhD 1
UNIVERSITY OF MIAMI Curriculum Vitae
1. Date: February 9, 2020
I. PERSONAL
2. Name: Kathryn E. McCollister, Ph.D.
3. Office Phone: (305) 243−3479
4. Address: 1120 NW 14th Street, Suite 1019, Miami FL 33136
5. Current Academic Rank: Associate Professor
6. Current Track of Appointment Award of Tenure: June 1,
2013
6a. Primary Department: Public Health Sciences, School of
Medicine
7. Secondary/Joint Appointments: Health Sector Management and
Policy, Miami Business School
II. HIGHER EDUCATION
8. Institutional
Florida International University, Miami, FL Ph.D. Economics
1999
Florida International University, Miami, FL M.A. Economics
1997
The George Washington University, Washington, DC B.A.
International Affairs 1993
9. Non−Institutional: N/A
10. Certification, licensure: N/A
III. EXPERIENCE
11. Academic Positions
Associate Professor (awarded tenure in 2013) 2013 −Present
University of Miami Miller School of Medicine Department of Public
Health Sciences
Assistant Professor tenure−earning track 2007 to 2013 University
of Miami Miller School of Medicine Department of Epidemiology and
Public Health
Research Assistant Professor 1999 to 2006 University of Miami
Miller School of Medicine
-
Kathryn E. McCollister Ph.D.
2
Department of Epidemiology and Public Health
Senior Research Associate 1998 to 1999
University of Miami Miller School of Medicine Health Services
Research Center
Instructor 1997 to 1999 Florida International University
Department of Economics
Teaching Associate 1995 to 1997 Florida International University
Department of Economics
12. Hospital Appointments: N/A
13. Non−Academic Positions: N/A
14. Military: N/A
-
Kathryn E. McCollister Ph.D.
3
IV. PUBLICATIONS
15. Books and monographs published:
a. McCollister, K.E., Muennig, P., Davila, E., Lee, D.J.,
LeBlanc, W., Fleming, L.E., Caban−Martinez, A., Ocasio, M., Clarke,
T., Arheart, K., and Sestito, J. “Health−Adjusted Life Years and
Burden of Disease by NORA Sectors: The National Health Interview
Survey (NHIS) 1986−1996.” Monograph available at Study Website:
www.umiamiorg.com
b. Fleming, L.E., Pitman, T., LeBlanc, W.G., Lee, D.J.,
Caban−Martinez, A.J., Arheart, K.L., McCollister, K.E., and Chung
Bridges, K. “Interactive Monograph of Occupation and Health
Disparities in the National Health Interview Survey (1997−2004).”
2007. Monograph available at Study Website:
www.rsmas.miami.edu/groups/niehs/niosh/
c. Zhang, S., Roberts, R., and McCollister, K. E. “Final Report
on the Cost Benefit Analysis of the Substance Abuse Program at the
California Substance Abuse Treatment Facility and State Prison at
Corcoran.” San Diego, CA: San Diego State University, 2006.
d. McCollister, K.E., and M.T. French. “The Economic Cost of
Substance Abuse Treatment in Criminal Justice Settings.” In C.G.
Leukefeld, F. Tims, and D. Farabee (Eds.), Treatment of Drug
Offenders: Policies and Issues, New York: Springer Publishing
Company, 2−37, 2002.
e. McCollister, K.E. and Rosenberg, B.N. “Cost Effectiveness of
Rehabilitation Versus Incarceration.” In R. Morgan (Ed.), The SAGE
Encyclopedia of Criminal Psychology (Vol. 1, pp. 219-222). Thousand
Oaks, CA: SAGE Publications, Inc., 2019.
16. Juried or refereed journal articles or exhibitions: (*
Authors listed alphabetically)
(§ Based on dissertation work. Authors are typically listed
alphabetically in economics journals)
a. Jalali, A., Ryan, D., McCollister, K.E., Marsch, L.,
Schackman, B.R., and Murphy, S.M. “Economic Evaluation in the
National Drug Abuse Treatment Clinical Trials Network: Past,
Present, and Future.” In Press at the Journal of Substance Abuse
Treatment.
b. Zheng, D.D., Christ, S.L., Feaster, D.J., McCollister, K.E.,
Lam, B.L., and Lee, D.J. Patterns of Chronic Conditions and Their
Association with Visual Impairment and Healthcare Utilization -
Application of Latent Class Analysis. In Press, JAMA
Ophthalmology.
c. Reckers-Droog, V.T., Goorden, M., Dijkgraaf, M.G.W., Van
Eeren, H.V., McCollister, K.E., Hakkaart-van Roijen, L. “Unit Costs
of Delinquent Acts for Use in Economic Evaluations.” The Journal of
Mental Health Policy and Economics, 22: 71-79, 2019.
d. Bowser, D., Henry, B. F., & McCollister, K. E. “An
Overlapping Systems Conceptual Framework to Evaluate Implementation
of a Behavioral Health Intervention for Justice– Involved Youth.”
Health Services Insights, 2019.
e. Murphy S.M., McCollister K.E., Leff JA, Yang X, Jeng PJ, Lee
JD, Nunes EV, Novo P, Rotrosen J, Schackman BR. “Cost-Effectiveness
of Extended-Release Naltrexone versus
http://www.umiamiorg.com/http://www.rsmas.miami.edu/groups/niehs/niosh/
-
Kathryn E. McCollister Ph.D.
4
Buprenorphine-Naloxone to Prevent Opioid Relapse among
Individuals Initiating Treatment In an Inpatient Detoxification
Setting.” Annals of Internal Medicine, 2018.
f. McCollister, K.E., Yang, X., Murphy, S.M., Leff, J.A.,
Kronmal, R.A., Crane, H.M., Chandler, R.K., Taxman, F.S., Feaster,
D.J., Metsch, L., Cunningham, W.E., Altice, F.L., Schackman, B.R.
“Criminal Justice Measures for Economic Data Harmonization in
Substance Use Disorder Research.” Health and Justice, 6(1),
2018.
g. McCollister, K.E., Leff, J.A., Yang, X., Lee, J.D., Nunes,
E.V., Novo, P., Rotrosen, J., Schackman, B.R., Murphy, S.M. (In
Press). Cost of Pharmacotherapy for Opioid Use Disorders Following
Inpatient Detoxification.” American Journal of Managed Care,
24(11): 526-531, 2018.
h. Peterson, C., Kearns, M.C., McIntosh, W.L., Estefan, L.F.,
Nicolaidis, C., McCollister, K.E., Nygren, P., Gordon, A.,
Florence, C. “Lifetime Economic Burden of Intimate Partner Violence
Among United States Adults.” American Journal of Preventive
Medicine.55(4): 433-444, 2018.
i. McCollister, K.E., Baumer, P., Davis, M., Greene, A.,
Stevens, S., and Dennis, M.L. “Economic Evaluation of the Juvenile
Drug Court Reclaiming Futures Model.” Journal of Behavioral Health
Services and Research, 45 (3), 321-339, 2018.
j. Becan JE, Bartkowski JP, Knight DK, Wiley TRA, DiClemente R,
Ducharme L, Welsh WN, Bowser D, McCollister KE, Hiller M, Spaulding
AC, Flynn PM, Swartzendruber A,
Dickson MF, Fisher JH, Aarons GA. “A Model for Rigorously
Applying the Exploration, Preparation, Implementation, Sustainment
Framework in the Design and Measurement of a Large Scale
Collaborative Multi-Site Study.” Health and Justice, 6:9, 2018.
k. Murphy, S.M., Leff, J.A., Linas, B.P., Morgan, J.R.,
McCollister, K.E., Schackman, B.R. “Implementation of a nationwide
health economics consultation service to assist substance use
researchers: Lessons learned.” Substance Abuse Journal, Mar 20,
1-19, 2018.
l. McCollister, K.E., Yang, X., Sayed, B., French, M.T., Leff,
J.A., Schackman, B.R. “Monetary Conversion Factors for Economic
Evaluations of Substance Use Disorders.” Journal of Substance Abuse
Treatment, 81, 25-34, 2017.
m. Hartzler, B., Lyon, A.R., Walker, D.D., Matthews, L., King,
K.M., McCollister, K.E. “Implementing the Teen Marijuana Check-Up
In Schools.” Implementation Science, Aug 10;12(1): 103, 2017.
n. Prendergast, M., McCollister, K.E., and Warda, Umme. “A
Randomized Study of the Use of Screening, Brief Intervention, and
Referral to Treatment (SBIRT) with Jail Inmates.” Journal of
Substance Abuse Treatment, Mar; Vol 74: 54-64, 2017.
o. Farabee, D., Hillhouse, M., Condon, T., McCrady, B.,
McCollister, K.E., Ling, W. “Injectable Pharmacotherapy for Opioid
Use Disordr (IPOD).” Contemporary Clinical Trials, Jul; 49:70-7,
2016.
p. Chandler, R.K., Finger, M.S., Farabee, D., Schwartz, R.P.,
Condon, T., Dunlap, L.J., Zarkin, G.A., McCollister, K, McDonald,
R.D., Laska, E., Bennett, D., Kelly, S.M., Hillhouse, M., Mitchell,
S.G., O’Grady, K.E., Lee, J.D. “The
-
Kathryn E. McCollister Ph.D.
5
SOMATICS Collaborative: Introduction to a National Institute on
Drug Abuse Cooperative Study of
-
Kathryn E. McCollister Ph.D.
6
Pharmacotherapy for Opioid Treatment in Criminal Justice
Settings.” Contemporary Clinical Trials, May; 48:166-72, 2016.
q. McCollister, K.E., Yang, X., and McKay, J.
“Cost-Effectiveness Analysis of a Continuing Care Intervention for
Patients with Cocaine Dependence.” Drug and Alcohol Dependence,
158: 38-44, 2016.
r. Moon, C.S., Nanji, A.A., Galor, A., McCollister, K.E., and
Karp, C.L. “Surgical Versus Medical Treatment of Ocular Surface
Squamous Neoplasia: A Comparison of Costs.” Ophthalmology, 123(3):
497-504, 2016.
s. McCollister, K.E., Tolbert, D.V., Mishra, S., Natale, R., and
Messiah, S.E. “Cost Analysis of a Childcare Center-Based
Intervention to Prevent Obesity in the Preschool Years.” Journal of
Comprehensive Pediatrics May; 6(2): e25845, 2015.
t. Fernandez, C.A., Christ, S.L., LeBlanc, W.G., Arheart, K.L.,
Dietz, N. A., McCollister, K.E., Fleming, L.E., Muntaner, C.,
Muennig, P., and Lee, D.J. “Effect of Childhood Victimization on
Future Occupational Prestige and Income Trajectories.” PLOS One,
10(2), 2015.
u. McCollister, K.E., Scott, C.K., Dennis, M.L., Freitas, D.M.,
French, M.T., and Funk, R. “Economic Costs of a Post−Release
Intervention for Incarcerated Female Substance Abusers: Recovery
Management Checkups for Women Offenders (RMCWO).” Journal of
Offender Rehabilitation, 53(7): 543-561, 2014.
v. Tolbert, D.V., McCollister, K.E., LeBlanc, W.G., Lee, D.J.,
Fleming, L.E., and Muennig,
P. “The Economic Burden of Disease by Industry: Differences in
Quality‐adjusted Life Years and Associated Costs.” American Journal
of Industrial Medicine, 57(7), 757-763, 2014.
w. McCollister, K.E., Freitas, D., Prado, G., and Pantin, H.
“Opportunity Cost and Financial Incentives for Participation in a
Family−based HIV and Substance Use Preventive Intervention for
Hispanic Youth.” Journal of Primary Prevention, 35(1): 13-20,
2014.
x. McCollister, K.E., French, M.T., Freitas, D., Dennis, M.L.,
Scott, C.K., and Funk, R.
“Cost−effectiveness Analysis of Recovery Management Checkups
(RMC) for Adults with Chronic Substance Use Disorders: Evidence
from a Four-year Randomized Trial.” Addiction, 108(12): 2166-74,
2013.
y. Galor, A., Zheng, D.D., Arheart, K.L., Lam, B.L.,
McCollister, K.E., Ocasio, M.A., Fernandez, C.A., and Lee, D.J.
“Influence of Socio−Demographic Characteristics on Eye Care
Expenditure: Data from the Medical Expenditure Panel Survey 2007.”
Ophthalmic Epidemiology, Early Online 1-6, 2013.
z. Prado, G., Cordova, D., Huang, S., Estrada, Y., Rosen, A.,
Bacio, G.A., Jimenez, G.L., Pantin, H., Brown, C.H., Velazquez,
M.R., Villamar, J., Freitas, D., Tapia, M.I., and McCollister, K.E.
“The Efficacy of Familias Unidas on Drug and Alcohol Outcomes for
Hispanic Delinquent Youth: Main Effects and Effects by
Environmental Context.” Drug and Alcohol Dependence, 125, S1:
S18−S25, 2012.
aa. McCollister, K.E., Zheng, D.D., Fernandez, C., Lee, D.J.,
Lam, B.L., Arheart, K.L., Galor, A., Ocasio, M., and Muennig, P.
“Racial Disparities in Quality−Adjusted Life Years (QALYs)
Associated with Diabetes and Visual Impairment.” Diabetes Care, 35:
1692−1694, 2012.
-
Kathryn E. McCollister Ph.D.
7
bb. Galor, A., Zheng, D.D., Arheart, K.L., Lam, B.L., Perez,
V.L., McCollister, K.E., Ocasio, M., McClure, L.A., and Lee, D.J.
“Dry Eye Medication Use and Expenditures: Data from the Medical
Expenditure Panel Survey 2001−2006.” Cornea 1−5, 2012.
cc. Caban−Martinez, A.J., Davila, E.P., Lam, B.L., Arheart,
K.L., McCollister, K.E., Fernandez, C. A., Ocasio, M.A., and Lee,
D.J. “Sociodemographic Correlates of Eye Care Provider Visits in
the 2006−2009 Behavioral Risk Factor Surveillance Survey.” BMC
Research Notes 5: 253, 2012.
dd. *Alexandre, P.K., Beulaygue, I., French, M.T., McCollister,
K.E., Popovici, I., and Sayed, B.A. “The Economic Cost of Substance
Abuse Treatment in the State of Florida.” Evaluation Review 36(3):
167−185, 2012.
ee. Arheart, K.L., Fleming, L.E., Lee, D.J., Leblanc, W.G.,
Caban−Martinez, A.J., Ocasio, M.A., McCollister, K.E., Christ,
S.L., Clarke, T., Kachan, D., Davila, E.P., and Fernandez, C.A.
“Occupational vs. Industry Sector Classification of the U.S.
Workforce: Which Approach is More Strongly Associated with Worker
Health Outcomes?” American Journal of Industrial Medicine,
54(10):748−757, 2011.
ff. Lam, B.L., Zheng, D., Davila, E.P., Arheart, K.L., Ocasio,
M.A., McCollister, K.E., Caban−Martinez, A.J., and Lee, D.J.
“Trends in Glaucoma Medication Expenditure: Medical Expenditure
Panel Survey: 2001−2006.” Archives of Ophthalmology, 129(10):
1345−50, 2011.
gg. Dy, C.J., McCollister, K.E., Lubarsky, D.A., and Lane, J.M.
“An Economic Evaluation of a Systems−Based Strategy to Expedite
Surgical Repair of Hip Fractures.” Journal of Bone and Joint
Surgery, 93(14): 1326−34, 2011.
hh. *Dennis, M.L., French, M.T., McCollister, K.E., and Scott,
C.K. “The Economic Costs of Quarterly Monitoring and Recovery
Management Checkups for Adults with Chronic Substance Use
Disorders.” Journal of Substance Abuse Treatment, 41(2): 201−207,
2011.
ii. Lewis, J.E., Clark, J.D. 3rd, LeBlanc, W G., Fleming, L.E.,
Cabán−Martinez, A.J., Arheart, K.L., Tannenbaum, S.L., Ocasio,
M.A., Davila, E.P., Kachan, D., McCollister, K.E., Dietz, N.,
Bandiera, F.C., Clarke, T.C., and Lee, D.J. “Cardiovascular Fitness
Levels among American Workers.” Journal of Occupational and
Environmental Medicine, 53(10): 1115−21, 2011.
jj. Caban−Martinez, A.J., Lee, D.J., Fleming, L.E., Arheart,
K.L., LeBlanc, W.G., McCollister, K.E., Christ, S.L., Louie, G.H.,
Tancredi, D.J., and Muennig, P. “Arthritis, Occupational Class, and
the Aging U.S. Workforce.” American Journal of Public Health,
101(9): 1729−34, 2011.
kk. Caban−Martinez, A.J., Davila, E.P., Lam, B.L., Dubovy, S.R.,
McCollister, K.E., Fleming, L.E., Zheng, D., and Lee, D.J.
“Age−related Macular Degeneration and Smoking Cessation Advice by
Eye Care Providers: A Pilot Study.” Preventing Chronic Disease,
8(6):A147, 2011.
ll. Dietz, N.A., Lee, D.J., Fleming, L.E., LeBlanc, W.G.,
McCollister, K.E., Arheart, K.L., Davila, E.P., and Caban−Martinez,
A.J. “Trends in Smokeless Tobacco Use in the U.S. Workforce: 1987–
2005.” Tobacco Induced Diseases, 9:6 (1 June 2011).
mm. Caban−Martinez, A.J., Lee, D.J., Goodman, E., Davila, E.P.,
Fleming, L. E., LeBlanc, W.G, Arheart, K.L., McCollister, K.E.,
Christ, S.L., Zimmerman, F.J., Muntaner, C., and Hughes, D. “Health
Indicators among Unemployed and Employed Young Adults.” Journal of
Occupational & Environmental Medicine, 53(2):196−203, 2011.
-
Kathryn E. McCollister Ph.D.
8
nn. Pyne, J., Tripathi, S., French, M.T., McCollister, K.E.,
Rapp, R., and Booth, B. “Longitudinal Association of
Preference−Weighted Health−Related Quality of Life Measures and
Substance Use Disorder Outcomes.” Addiction, 106(3): 507−515,
2011.
oo. Zhang, S., Roberts, B., and McCollister, K.E. “Therapeutic
Community in a California Prison: Treatment Outcomes after Five
Years.” Crime and Delinquency, 57(1) 82–101, 2011.
pp. Davila, E.P., Florez, H., Fleming, L.E., Lee, D.J., Goodman,
E., LeBlanc, W.G., Caban−Martinez, A.J., Arheart, K.L.,
McCollister, K.E., Christ, S.L., Clark, J.C., and Clarke, T.
“Prevalence of the Metabolic Syndrome among U.S. Workers.” Diabetes
Care, 33(11): 2390−2395, 2010.
qq. Davila, E.P., Lee, D.J., Fleming, L.E., LeBlanc, W.G.,
Arheart, K.L., Dietz, N., Lewis, J.E., McCollister, K.E., and
Caban−Martinez, A.J. “Sleep Disorders and Secondhand Smoke Exposure
in the U.S. Population.” Nicotine and Tobacco Research, 12:
294−299, 2010.
rr. Davila, E.P., Christ, S.L., Caban−Martinez, A.J., Lee, D.J.,
Arheart, K.L., LeBlanc, W.G., McCollister, K. E., Clarke, T.,
Zimmerman, F., Goodman, E., Muntaner, C., and Fleming, L.E. “Young
Adults, Mortality, and Employment.” Journal of Occupational &
Environmental Medicine, 52(5): 501−4, 2010.
ss. Caban−Martinez, A.J., Lee, D.J., Davila, E.P., LeBlanc,
W.G., Arheart, K. L., McCollister, K.E., Christ, S. L., Clarke, T.,
and Fleming, L.E. “Sustained Low Influenza Vaccination Rates in US
Healthcare Workers.” Preventive Medicine, 50(4): 210−2, 2010.
tt. McCollister, K.E., French, M.T., and Fang, H. “The Cost of
Crime to Society: New Crime−Specific Estimates for Policy and
Program Evaluation.” Drug and Alcohol Dependence, 108: 98–109,
2010.
uu. Bandiera, F.C., Arheart, K.L., Caban−Martinez, A.J.,
Fleming, L.E., McCollister, K.E., Dietz, N.A., LeBlanc, W.G.,
Davila, E.P., Lewis, J.E., Serdar, B., and Lee, D.J. “Second Hand
Smoke Exposure and Depressive Symptoms.” Psychosomatic Medicine,
72: 68−72, 2010.
vv. Vidal, L., LeBlanc, W.G., McCollister, K.E., Arheart, K.L.,
Chung−Bridges, K., Christ, S., Caban−Martinez, A.J., Lewis, J. Lee,
D.J., Clark III, J., Davila, E., and Fleming, L.E. “Cancer
Screening in U.S. Workers.” American Journal of Public Health, 99:
59−65, 2009.
ww. McCollister, K.E., French, M.T., Sheidow, A., Henggeler,
S.W., and Halliday−Boykins, C.A. “Estimating the Differential Costs
of Criminal Activity for Juvenile Drug Court Participants:
Challenges and Recommendations.” Journal of Behavioral Health
Services and Research, 36(1): 111−126, 2009.
xx. Lee, D.J., Lam, B.L., Arora, S., Arheart, K.L., McCollister,
K.E., Zheng, D.D., Christ, S.L., Davila, E.P. “Reported Eyecare
Utilization among US Adults: The 1997−2005 National Health
Interview Survey.” Archives of Ophthalmology, 127(3): 303−310,
2009.
yy. Davila, E.P., Caban−Martinez, A.J., Muennig, P., Lee, D.J.,
Fleming, L., Ferraro, K.F., LeBlanc, W.G., Lam, B., Arheart, K.L.,
McCollister, K.E., Zheng, D., and Christ, S.L. “Sensory Impairment
in Older U.S. Workers.” American Journal of Public Health, 99(8):
1378−85, 2009.
zz. Lee, D.J., Arheart, K.L., Lam, B.L., Zheng, D.D., Christ,
S.L., McCollister, K.E., and Davila, E.P. “Trends in Reported
Visual Impairment in United States Adults.”
-
Kathryn E. McCollister Ph.D.
9
Ophthalmic Epidemiology, 16(1): 42−9, 2009.
-
Kathryn E. McCollister Ph.D.
10
aaa. McCollister, K.E., Arheart, K., Lee, D., Fleming, L.E.,
Chung−Bridges, K., Christ, S.L., LeBlanc, W., Caban−Martinez, A.J.,
and Davila, E. “Declining Health Insurance Coverage Among US
Workers: Not All Jobs Are Created Equal.” American Journal of
Industrial Medicine, 53(2): 163−70, 2009.
bbb. Zhang, S., Roberts, B., and McCollister, K.E. “An Economic
Analysis of the In−prison Therapeutic Community Model on Prison
Management Costs.” Journal of Criminal Justice, 37: 388–395,
2009.
ccc. McCollister, K.E., French, M.T., Pyne, J., Booth, B., Rapp,
R., and Carr, C. “The Cost of Treating Addiction from the Client’s
Perspective: Results from a Multi−Modality Application of the
Client DATCAP.” Drug and Alcohol Dependence, 104(3): 241−8,
2009.
ddd. Lewis, J.E., Arheart, K.L., LeBlanc, W.G., Fleming, L.E.,
Lee, D.J., Davila, E.P., Caban−Martinez, A.J., Dietz, N.A.,
McCollister, K.E., Bandiera, F.C., and Clark, J.D. Jr. “Food Label
Use and Awareness of Nutritional Information and Recommendations
among Persons with Chronic Disease.” American Journal of Clinical
Nutrition, 90(5): 1351−7, 2009.
eee. French, M.T., Zavala, S.K., McCollister, K.E., Waldron, H.,
Turner, C., and Ozechowski, T. “Cost−Effectiveness Analysis (CEA)
of Four Interventions for Adolescents with a Substance Use
Disorder.” Journal of Substance Abuse Treatment, 34(3): 272−81,
2008.
fff. Pyne, J.M., French, M.T., McCollister, K.E., Tripathi, S.,
Rapp, R., and Booth, B. “Preference−Weighted Health−Related Quality
of Life Measures and Substance Use Disorder Severity.” Addiction,
103(8): 1320−1329, 2008.
ggg. Chung−Bridges, K., Muntaner, C., Fleming, L.E., Lee, D.J.,
Arheart, K.L., LeBlanc, W.G., Christ, S.L., McCollister, K.E.,
Caban−Martinez, A.J., and Davila, E. “Occupational Segregation as a
Determinant of Worker Health.” American Journal of Industrial
Medicine, 51: 555−567, 2008.
hhh. Arheart, K.L., Lee, D.J., Fleming, L.E., LeBlanc, W.G.,
Dietz, N.A., McCollister, K.E., Wilkinson, J.D., Lewis, J.E.,
Clark, J.D., Davila, E.P., and Bandiera, F.C. “Accuracy of
Self−reported Smoking and Secondhand Smoke Exposure in the US
Workforce: the National Health and Nutrition Examination Surveys.”
Journal of Occupational and Environmental Medicine, 50(12):
1414−20, 2008.
iii. LeBlanc, W.G., Vidal, L., Kirsner, R.S., Lee, D.J.,
Caban−Martinez, A.J., McCollister, K.E., Arheart, K.L.,
Chung−Bridges, K., Christ, S.L., Clark, J., Lewis, J.E., Davila,
E.P., Rouhani, P., and Fleming, L.E. “Reported Skin Cancer
Screening of U.S. Adult Workers.” Journal of the American Academy
of Dermatology, 59(1): 55−63, 2008.
jjj. Fleming, L.E., Lee, D.J., Caban−Martinez, A.J., LeBlanc,
W.G., McCollister, K.E., Bridges Chung, K., Christ, S.L., Arheart,
K.L., and Pitman, T. “The Health Behaviors of the Older US Worker.”
American Journal of Industrial Medicine, 50: 427−437, 2007.
kkk. Lee, D.J., Fleming, L.E., Arheart, K.L., LeBlanc, W.G.,
Caban−Martinez, A.J., Chung Bridges, K., Christ, S.L., McCollister,
K.E., and Pitman, T. “Smoking Rate Trends in US Occupational
Groups: The 1987−2004 National Health Interview Survey (NHIS).”
Journal of Occupational and Environmental Medicine, Vol. 49 (1): 75
– 81, 2007.
lll. Caban−Martinez, A.J., Lee, D.J., Fleming, L.E., LeBlanc,
W.G., Arheart, K.L., Chung−Bridges, K., Christ, S.L., McCollister,
K.E., and Pitman, T. “Leisure−Time Physical Activity Levels of the
U.S. Workforce.” Preventive Medicine, 44: 432−436, 2007.
mmm. Lee, D.J., Fleming, L.E., McCollister, K.E.,
Caban−Martinez, A.J., Arheart,
-
Kathryn E. McCollister Ph.D.
11
K.L., LeBlanc, W.G., Chung−Bridges, K., Christ, S.L., Dietz, N.,
and Clark, JD. “Healthcare
-
Kathryn E. McCollister Ph.D.
12
Provider Smoking Cessation Advice among US Worker Groups.”
Tobacco Control, 16: 325−328, 2007.
nnn. Christ, S.L., Lee, D., Fleming, L.E., LeBlanc, W., Arheart,
K., Chung−Bridges, K., Caban−Martinez, A.J., and McCollister, K.E.
“Employment and Occupation Effects on Depressive Symptoms in Older
Americans: Does Working Past Age 65 Protect Against Depression?”
Journal of Gerontology: Social Sciences, 62(6): S399−403, 2007.
ooo. *§Karayalcin, A.C., and McCollister, K.E. “Income
Distribution, Sovereign Debt, and Public Investment.” Economics and
Politics, 17(3): 351−365, 2005.
ppp. French, M.T., McCollister, K.E., Alexandre, P.K., Chitwood,
D., and McCoy, C.B. “Revolving Roles in Drug−Related Crime: The
Cost of Chronic Drug Users as Victims and Perpetrators.” Journal of
Quantitative Criminology, 20(3): 217−241, 2004.
qqq. Logan, T., Hoyt, W., McCollister, K.E.., French, M.,
Leukefeld, C., and Minton, L. “Economic Evaluation of Drug Court:
Methodology, Results, and Policy Implications.” Evaluation and
Program Planning, 27(4): 381−396, 2004.
rrr. McCollister, K.E., French, M.T., Prendergast, M.L., Hall,
E. and Sacks, S. “Long−Term Cost−Effectiveness of Addiction
Treatment for Criminal Offenders: Evaluating Treatment History and
Reincarceration Five Years Post−Parole.” Justice Quarterly, 21(3):
659−679, 2004.
sss. McCollister, K.E., French, M.T., Prendergast, M., Wexler,
H., Sacks, S., and Hall, E. “Is In−Prison Treatment Enough? A
Cost−Effectiveness Analysis of Prison−Based Treatment and Aftercare
Services for Substance Abusing Offenders.” Law and Policy, 25 (1):
62−83, 2003.
ttt. McCollister, K.E., and French, M.T. “The Relative
Contribution of Outcome Domains in the Total Economic Benefit of
Addiction Interventions: A Review of First Findings.” Addiction,
98: 1647−1659, 2003.
uuu. McCollister, K.E., French, M.T., Inciardi, J.A., Butzin,
C.A., Martin, S.S., and Hooper, R.M. “Post−Release Substance Abuse
Treatment for Criminal Offenders: A Cost−Effectiveness Analysis.”
Journal of Quantitative Criminology, 19(4): 389−407, 2003.
vvv. French, M.T., McCollister, K.E., Sacks, S., McKendrik, K.,
and De Leon, G. “Benefit−Cost Analysis of a Modified Therapeutic
Community for Mentally Ill Chemical Abusers.” Evaluation and
Program Planning, 25(2): 137−148, 2002.
www. French, M.T., McCollister, K.E., Cacciola, J., Durell, J.,
and Stephens, R. L. “Benefit−Cost Analysis of Addiction Treatment
in Arkansas: Specialty and Standard Residential Programs for
Pregnant and Parenting Women.” Substance Abuse, 23(1): 31−51,
2002.
xxx. Burbano, X., Miguez−Burbano, M.J., McCollister, K.E.,
Zhang, G., Rodriguez, A., Ruiz, P., Lecusay, R., and Shor−Posner,
G. “Impact of Selenium Chemoprevention Clinical Trial on Hospital
Admissions of HIV Infected Participants.” HIV Clinical Trials
Journal, 3(6): 483−91, 2002.
yyy. *§Karayalcin, A.C., McCollister, K.E., and Mitra, D.
“Infrastructure, Returns to Scale, and Sovereign Debt.” Journal of
International Trade and Economic Development, 11 (3): 267−279,
2002.
17. Other works, publications, abstracts:
-
Kathryn E. McCollister Ph.D.
13
1. McCollister, K.E. “Cost Effectiveness of Substance Abuse
Treatment in Criminal Justice Settings.” Knowledge Asset Web site
created by the Robert Wood Johnson Foundation's Substance Abuse
Policy Research Program; July 2008.
http://saprp.org/knowledgeassets/knowledge_detail.cfm?KAID=10
2. McCollister, K.E. “Estimating Victim Costs of Crime for
Cost−benefit Analyses in Criminal Justice.” VERA Institute for
Justice. Cost−benefit Knowledge Bank Webinar on Demystifying Crime
Victim Costs (with T. Stanford and V. Levshin). VERA Victim Costs
Webinar
3. McCollister, K.E., Baumer, P., and the University of Arizona
- Southwest Institute for Research on Women (2015). Cross-Site
Report: Cost Analysis Overview and Results Narrative – March 2015.
The University of Arizona: Tucson, Arizona.
18. Other Works, Invited Revise/Resubmit or Accepted for
Publication
The OUD Modeling Group (includes McCollister, K.E.). “How
simulation modeling can support the public health response to the
opioid crisis in North America: setting priorities and assessing
value.” Invited Revise & Resubmit at International Journal of
Drug Policy.
Onuoha E.O., Leff J.A., Schackman B.R., McCollister K.E., Polsky
D., Murphy S.M. Recent Economic Evaluations of Pharmacological
Treatment for Opioid Use Disorder: A Systematic Literature Review.
Invited Revise & Resubmit at Value in Health.
V. PROFESSIONAL
19. Funded Research
KENTUCKY CAN (Communities and Networks) HEAL (Helping End
Addiction Long-term) Principal Investigator: Sharon Walsh, PhD
(University of Kentucky) Role: Principal Investigator of
Subcontract and Health
Economics Lead for Kentucky (20%) Grant # UM1DA049406 Funding
Source: National Institute on Drug Abuse Project Period:
07/01/19-06/30/2023 Total Award: $77,741 (direct)
HEALING COMMUNITIES STUDY: DATA COORDINATING CENTER Principal
Investigator: Richard Williams, PhD
Role: Principal Investigator of Subcontract and Health Economics
Representative for Kentucky (10%)
Grant # Funding Source: National Institute on Drug Abuse Project
Period: 07/01/19 – 06/30/23 Total Award: $23,777 (direct)
ORGANIZATIONAL AND ENVIRONMENTAL FACTORS INFLUENCING
IMPLEMENTATION OF EVIDENCE-BASED PRACTICES IN JUVENILE JUSTICE
SETTINGS
http://saprp.org/knowledgeassets/knowledge_detail.cfm?KAID=10http://www.slideshare.net/CBKBank/110721-victim-costs-webinar-final-9595708http://www.slideshare.net/CBKBank/110721-victim-costs-webinar-final-9595708http://www.slideshare.net/CBKBank/110721-victim-costs-webinar-final-9595708
-
Kathryn E. McCollister Ph.D.
14
Principal Investigator: Kathryn E. McCollister, PhD Role:
Principal Investigator (20%) Grant # R21DA044378 Funding Source:
National Institute on Drug Abuse Project Period: 07/01/17 –
06/30/20 Total Award: $430,591
CHERISH: CENTER FOR HEALTH ECONOMICS OF TREATMENT INTERVENTIONS
FOR SUBSTANCE USE DISORDER, HCV, AND HIV Principal Investigator:
Bruce R. Schackman, PhD, MBA Role: Principal Investigator of
Subcontract and Co-Director of the
Methodology Core (20%) Grant # P30DA040500 Funding Source:
National Institute on Drug Abuse Project Period: 07/01/15 –
04/30/20 Total Award: $288,827
EVALUATION OF LIFE-STEPS TO ENHANCE ADHERENCE AND ENGAGEMENT IN
PREP CARE Principal Investigator: Steven Safren, PhD Role:
Co-Investigator and Health Economics Lead (15%) Grant #: MH118043
Funding Source: National Institute on Mental Health Project Period:
07/15/19-04/30/24
Total Award:
EVALUATING THE EFFECTIVENESS OF AN eHEALTH EVIDENCE BASED
INTERVENTION FOR LATINO YOUTH IN PRIMARY CARE Principal
Investigator: Guillermo (Willy) Prado, PhD Role: Co-Investigator
(20%) Grant # R01 DA040756 Funding Source: National Institute on
Drug Abuse Project Period: July 1, 2016 – April 30, 2021 Total
Award: $795,348
MYTPILL: A NOVEL STRATEGY TO MONITOR ANTIRETROVIRAL ADHERENCE
AMONG HIV+ PRESCRIPTION OPIOID USERS Principal Investigator: Boyer,
PhD Role: Co-Investigator on subcontract to Dr. Carrico (10%) Grant
# R01DA047236 Funding Source: National Institute on Drug Abuse
Project Period: 06/01/19 – 04/30/23 Total Award: $170,692
MASSACHUSETTS JUSTICE COMMUNITY OPIOID INNOVATION NETWORK
(JCOIN), CLINICAL RESEARCH CENTER Principal Investigator: Peter
Friedmann, Ph.D. and Liz Evans, Ph.D. Role: Principal Investigator
of subcontract and co-lead of health
economic analysis (10%) Grant #: UG1DA050067 Funding Source:
National Institute on Drug Abuse
-
Kathryn E. McCollister Ph.D.
15
Project Period: 07/15/19-04/30/24 Total Award: $47,181
(direct)
IMPROVING RETENTION ACROSS THE OUD SERVICE CASCADE UPON REENTRY
FROM JAIL USING RECOVERY MANAGEMENT CHECKUPS Principal
Investigator: Christy K. Scott, PhD Role: Principal Investigator of
Subcontract and Health Economics Lead
(15%) Grant #: UG1DA050065 Funding Source: National Institute on
Drug Abuse Project Period: 07/15/19-04/30/24 Total Award: $64,533
(direct)
KENTUCKY WOMEN’S JUSTICE COMMUNITY OPIOID INNOVATION NETWORK (W-
JCOIN) CLINICAL RESEARCH CENTER Principal Investigator: Michele
Staton, PhD Role: Principal Investigator of Subcontract and Health
Economics Lead
(15%) Grant #: UG1DA050069 Funding Source: National Institute on
Drug Abuse Project Period: 07/15/19-04/30/24 Total Award: $73,075
(direct)
TRANSITIONS CLINIC NETWORK: POST INCARCERATION ADDICTION
TREATMENT, HEALTHCARE, AND SOCIAL SUPPORT (TCN PATHS) STUDY
Principal Investigator: Emily Wang, PhD Role: Principal
Investigator of Subcontract and Health Economics Lead
(15%) Grant #: UG1DA050062 Funding Source: National Institute on
Drug Abuse Project Period: 07/15/19-04/30/24
Total Award: $71,911 (direct)
PREVENTING OPIOID USE AMONG JUSTICE-INVOLVED YOUTH AS THEY
TRANSITION TO ADULTHOOD: LEVERAGING SAFE ADULTS (LeSA) Principal
Investigator: Danica K. Knight, PhD Role: Principal Investigator of
Subcontract and Health Economics Lead
(3%) Grant #: UG3DA050250 Funding Source: National Institute on
Drug Abuse Project Period: 12/1/2019 – 11/30-2024
Total Award: $26,368 (direct)
Completed:
LEVERAGING UNTAPPED OPPORTUNITIES IN PLACE AND TIME: A
COMMUNITY-
BASED CHILD WELL-BEING COLLABORATIVE [Phase 2019 Project for the
University of Miami Laboratory for Integrative Knowledge (U-LINK)]
Principal Investigator: Rebecca B. Shearer, PhD Role: Team Member
(5%) Grant # U-LINK 19-781
-
Kathryn E. McCollister Ph.D.
16
Funding Source: University of Miami Project Period: 01/02/2019 –
08/31/2019
Total Award: $40,000
KIIDS – KNOWING ABOUT INTERVENTION IMPLEMENTATION IN DETENTION
SITES Principal Investigator: R. DiClemente, PhD Role: Principal
Investigator on Subcontract (10%) Grant # 5U01DA036233-02 Funding
Source: National Institute on Drug Abuse Project Period: 07/01/2013
– 06/30/2018 Total Award: $433,508
JJ-TRIALS: THE JUVENILE JUSTICE TRANSLATIONAL RESEARCH ON
ADOLESCENTS IN THE LEGAL SYSTEM COST ANALYSIS PROTOCOL SUPPLEMENT
Principal Investigator: Kathryn McCollister Role: Principal
Investigator on Supplement from Emory
University (20%) Grant # U01DA036233 Funding Source: National
Institute on Drug Abuse Project Period: 07/01/15 – 06/30/16
Total Award: $ 151,965
ECONOMIC EVALUATION OF RECOVERY MANAGEMENT CHECKUPS FOR WOMEN
OFFENDERS (RMC−WO) Principal Investigator: Kathryn E. McCollister,
PhD Role: Principal Investigator (30%) Grant # R01 DA031785 Funding
Source: National Institute on Drug Abuse Project Period: 07/2011 –
07/2015 Total Award: $1,104,340
FAMILY INTERVENTION FOR TEEN DRINKING AND ALCOHOL−RELATED CRISES
IN THE ER Principal Investigator: Cynthia Rowe, PhD Role:
Investigator (10%) Grant # 1R01AA016186 Funding Source: National
Institute on Alcohol Abuse and Alcoholism Project Period:
05/01/2010 – 04/30/2015 Total Award: $3,020,544
FAMILIAS UNIDAS STAGE III STUDY: PREVENTING SUBSTANCE USE IN
HISPANIC YOUTH Principal Investigator: Guillermo Prado, PhD Role:
Collaborator (10%) Grant # 1R01DA025192 Funding Source: National
Institute on Drug Abuse Project Period: 12/05/2008 – 11/30/2014
Total Award: $3,291,964
-
Kathryn E. McCollister Ph.D.
17
INNOVATIONS FOR MEDICAID SCHOOL CHILDREN AND THEIR PARENTS IN
FLORIDA Principal Investigator: Jocelyn Lawrence, M.D. Role: Health
Economist/Collaborator (20%) Grant # CMS−1C1−331028 Funding Source:
Centers for Medicare and Medicaid Services Project Period: 06/2012
– 05/2015 Total Award:
SURVEILLANCE OF MORTALITY AND MORBIDITY IN US WORKERS Principal
Investigator: David Lee, PhD Role: Investigator (10%) Grant # R01
OH003915 Funding Source: National Institute for Occupational Safety
and Health Project Period: 9/2006 – 8/2013
Total Award: $1,223,841
PREVENTING DRUG ABUSE AND HIV IN HISPANIC FIRST OFFENDERS
Principal Investigator: Guillermo Prado, PhD Role: Investigator
(10%) Grant # R01 DA025894 Funding Source: National Institute on
Drug Abuse Project Period: 06/2009 – 05/2013 Total Award:
$650,633
HEALTHY CAREGIVERS; HEALTHY CHILDREN Principal Investigator: R.
Natale; S. Messiah; L. Sanders; A. Delamater Role: Investigator
(10% in year 3) Grant # 2009−05065 Funding Source: U.S. Department
of Agriculture Project Period: 04/2010 – 03/2013 Total Award:
$1,000,000
HEALTH AND ECONOMIC ASPECTS OF OCULAR DISEASE IN THE U.S.
Principal Investigator: David Lee, PhD Role: Investigator (7%)
Grant # R21 EY019096 Funding Source: National Eye Institute Project
Period: 09/2010 – 08/2012 Total Award: $191,252
PROJECT STRIDE: MULTISITE ECONOMIC COST ANALYSIS OF CTN PROTOCOL
0037 Principal Investigator: Kathryn McCollister, PhD (PI of FL
Node: Jose
Szapocznik) Role: PI of Ancillary Study (30%) Grant # U10
DA13720 Funding Source: National Institute on Drug Abuse Project
Period: 05/2011 – 08/2011
Total Award: $ 108,763
-
Kathryn E. McCollister Ph.D.
18
LONG−TERM OUTCOMES AND ECONOMIC IMPACT OF THE DETENTION TO
COMMUNITY MODEL Principal Investigator: Cynthia Rowe, Ph.D. Role:
Co−Investigator (5%) Grant #: 1R01 DA026126 Funding Source:
National Institute on Drug Abuse Project Period: 09/2009 –
08/2011
Total Award: $1,075,678
ECONOMIC EVALUATION METHODS: DEVELOPMENT AND APPLICATIONS
Principal Investigator: Michael French, Ph.D. Role: Investigator
(10%) Grant # R01 DA018645 Funding Source: National Institute on
Drug Abuse/NIH Project Period: 05/2005 to 04/2012 Total Award:
$3,161,675
MORTALITY AND HEALTH DISPARITIES OF THE NEW NIOSH NORA AGENDA
Principal Investigator: David Lee, Ph.D. Role: Investigator (10%)
Grant # 211−2008−26814 Funding Source: NIOSH/CDC Project Period:
07/2008 – 06/2010
Total Award: $116,276
ECONOMIC EVALUATION OF SUBSTANCE ABUSE TREATMENT IN CRIMINAL
JUSTICE SETTINGS Principal Investigator: Kathryn E. McCollister,
Ph.D. Role: Principal Investigator Grant #: K01 DA013962 Funding
Source: National Institute on Drug Abuse Project Period: 04/2004 to
05/2009 Total Award: $595,836
EPIDEMIOLOGY OF VISUAL IMPAIRMENT: THE 1986−2002 NHIS Principal
Investigator: David Lee, Ph.D. Role: Investigator Grant # 1R03
EY016481 Funding Source: National Eye Institute Project Period:
09/2006 – 08/2008
Total Award: $458,313
REDUCING THE BURDEN OF TOBACCO−RELATED CANCERS IN FLORIDA
Principal Investigator: David Lee, Ph.D. Role: Investigator Grant
#: 06TSP−03 Funding Source: James and Esther King Biomedical
Research Program
Project Period: 07/2006 to 06/2008 Total Award: $999,973
-
Kathryn E. McCollister Ph.D.
19
BENEFIT−COST ANALYSIS OF THE CALIFORNIA SUBSTANCE ABUSE
TREATMENT FACILITY (CSATF) Principal Investigator: Sheldon Zhang,
Ph.D. Role: Co−Principal Investigator Grant #: CFDA C03.503 Funding
Source: Department of Corrections, State of California Project
Period: 7/2003 to 6/2006
Total Award: $100,000
WOMEN’S PRISON TC: OUTCOME, PROCESS, AND ECONOMIC ANALYSIS
Principal Investigator: JoAnn Sacks, Ph.D. Role: Senior Research
Investigator Grant #: unknown Funding Source: National Institute on
Drug Abuse Project Period: 10/2001 to 9/2006 Total Award:
$487,311
ECONOMIC COSTS AND BENEFITS OF ALCOHOL SERVICES AND
INTERVENTIONS Principal Investigator: Michael French, Ph.D. Role:
Project Director Grant #: R01 AA13167 Funding Source: National
Institute on Alcohol Abuse and Alcoholism Project Period: 4/2001 to
3/2006 Total Award: $2,640,929
COSTS AND BENEFITS OF PRISON−BASED TREATMENT PLUS AFTERCARE FOR
DRUG ABUSING OFFENDERS Principal Investigator: Kathryn E.
McCollister, PhD Role: Principal Investigator Grant # 041070
Funding Source: The Robert Wood Johnson Foundation Substance
Abuse
Policy Research Program (SAPRP) Project Period: 12/2000 –
11/2004 Total Award: $189,133
20. Editorial responsibilities:
Member of editorial board Journal of Substance Abuse Treatment
2012−Present
Member of editorial board PLOS One 2019 – Present
Member of editorial board International Journal of Excellence
in
Healthcare Management
2018 - Present
Manuscript referee for:
Health Affairs 2016-Present
JAMA 2017-Present
Journal of Mental Health Policy and Economics 2004−Present
Crime and Delinquency 2011−Present
Health Economics 2008−Present
-
Kathryn E. McCollister Ph.D.
20
Criminal Justice Policy Review 2011−Present
Drug and Alcohol Dependence 2008−Present
Addiction 2003−Present
Evaluation and Program Planning 2002−Present
Alcohol Research and Health 2002−Present
Justice Quarterly 2003−Present
Journal of Psychoactive Drugs 2002−Present
Journal of Substance Abuse Treatment 2002−Present
Journal of Behavioral Health Services & Research
2008–Present
Journal of Offender Rehabilitation 2013−Present
Value in Health 2013−Present
21. Professional and Honorary Organizations:
Member of:
Delta Omega Honorary Society in Public Health (Beta Sigma
Chapter) 2010–Present
American Society of Health Economists 2006−Present
International Health Economics Association 2000−Present
American Economic Association 2000−Present
American Public Health Association 2000−Present
22. Honors and Awards:
Graduate fee grant for academic achievement, State of Florida
1997−1999
Graduate assistantship, Department of Economics, 1995−1999
Florida International University
23. Post−Doctoral Fellowships: N/A
24. Other Professional Activities:
Grant Reviews:
National Institutes of Health (NIH), National Institute on Drug
Abuse (NIDA) 2012-present Ad−Hoc Reviewer
National Institutes of Health (NIH), National Institute on
Minority Health and Health 2017 Disparities (NIMHD), Ad-Hoc
Reviewer
National Institutes of Health (NIH), National Eye Institute
(NEI) 2005, 2012 Ad−Hoc Reviewer
Robert Wood Johnson Foundation, Substance Abuse Policy Research
Program 2000 – 2005
-
Kathryn E. McCollister Ph.D.
21
Ad−Hoc Reviewer
Centers for Disease Control and Prevention, Mentored Public
Health Research 2007 Scientist Development Award (K01); Ad−Hoc
Reviewer
Invited Workshops and Trainings
1. “Introduction to Economic Evaluation.” Pre-conference
workshop, National Drug Abuse
Treatment Clinical Trials Network (CTN) Annual Steering
Committee Meeting, March 22, 2020.
2. “Understanding the Economic Impact of Multisite and
Multisystem Interventions.” Co- presenters Kathryn E. McCollister,
PhD and Sean M. Murphy, PhD. Addiction Health Services Research
Annual Meeting Pre-Congress Workshop. October 16, 2019.
3. Expanding The Impact Of Substance Use Disorder Research:
Economic Analysis For Program And Policy Evaluation. Co-presenters
Kathryn E. McCollister, PhD and Sean M. Murphy, PhD. College on
Problems of Drug Dependence (CPDD) Conference Workshop. June 18,
2019.
4. Expanding The Impact Of Substance Use Disorder Research:
Economic Analysis For Program And Policy Evaluation. Co-presenters
Kathryn E. McCollister, PhD and Sean M. Murphy, PhD. Addiction
Health Services Research Annual Meeting Pre-Congress Workshop.
October 17, 2018.
5. An Introduction to Economic Evaluation in Substance Use
Disorder Research. Pre- conference workshop. Co-presenters Kathryn
E. McCollister, PhD and Sean M. Murphy, PhD. National Drug Abuse
Treatment Clinical Trials Network (CTN) Annual Steering Committee
Meeting. March 19, 2018.
6. New Insights Into the Economics of Substance Use Disorder
Treatment: Addressing the Opioid Epidemic. Pre-Congress Half-Day
Workshop at the International Health Economics Association World
Congress. Boston, Massachusetts, July 8-11, 2017.
Invited Presentations
National and International Conferences:
"Implementation of evidence based practices for substance use
disorders in juvenile justice settings: Evaluating costs across
implementation phases." Symposium presentation, Academy Health 12th
Annual Conference on the Science of Dissemination and
Implementation, Arlington, VA, December 4, 2019.
“Economic Analysis of Implementing Evidence Based Practices in
Juvenile Justice Settings:
Resource Utilization and Budget Impact Across Implementation
Phases.” Symposium presentation, Addiction Health Services Research
Annual Meeting, Park City, Utah, October 16 – 18, 2019
“Health Services Data Harmonization for Economic Evaluation of
Substance Use Disorder Treatment and Policy.” Poster presentation,
Addiction Health Services Research Annual Meeting, Savannah,
Georgia, October 17 – 19, 2018.
-
Kathryn E. McCollister Ph.D.
22
“Organizational and Environmental Factors Influencing
Implementation of Evidence-based Practices in Juvenile Justice
Settings.” Poster presentation, European Health Economics
Association (EuHEA), Biennial Conference. Maastricht, Netherlands,
July 11- 14, 2018.
“Cost Analysis of Implementing Evidence Based Practices in
Juvenile Justice Settings: Results From A Multisite Randomized
Trial.” Poster presentation, European Health Economics Association
(EuHEA), Biennial Conference. Maastricht, Netherlands, July 11- 14,
2018.
“Resources and associated costs of implementing pharmacotherapy
for opioid dependence initiated in inpatient detoxification
settings: Results from a multisite randomized clinical trial.”
Poster presentation at College on Problems of Drug Dependence
Annual Meeting, San Diego, California, June 10-14, 2018.
“Economic Data Harmonization for Substance Use Disorder
Research: Criminal Justice Measures.” Symposium presentation,
Addiction Health Services Research Annual Meeting. Madison,
Wisconsin, October 18-20, 2017.
“New Insights Into the Economics of Substance Use Disorder
Treatment: Addressing the Opioid Epidemic.” Pre-Congress Half-Day
Workshop at the International Health Economics Association World
Congress. Boston, Massachusetts, July 8-11, 2017.
“Resources and associated costs of implementing medication
assisted treatment for opioid dependence in inpatient
detoxification settings: Preliminary findings from a multisite
randomized clinical trial.” Symposium presentation, International
Health Economics Association World Congress. Boston, Massachusetts,
July 8-11, 2017.
“Economic Consequences of Substance Use Disorders, HCV, and HIV:
Monetary Conversion Factors for Program and Policy Evaluation.”
Symposium presentation, Addiction Health Services Research Annual
Meeting. Seattle, Washington, October 13-15, 2016.
“Estimating the Economic Consequences of Substance Use
Disorders: Monetary Conversion Factors for Program and Policy
Evaluation.” Symposium presentation, European Health Economics
Association Biennial Conference. University of Hamburg, Hamburg,
Germany. July 13 – 16, 2016.
“Economic Analysis of Implementing Evidence-Based Practices for
Substance Use Disorders in Juvenile Justice Settings.” Poster
presentation, European Health Economics Association Biennial
Conference. University of Hamburg, Hamburg, Germany. July 13 – 16,
2016.
“Economic Evaluation of the Juvenile Drug Court Reclaiming
Futures (JDCRF) Model.” Presented at the Addiction Health Services
Annual Research Conference, Marina del Rey, California, October 16,
2015.
“Cost-Effectiveness Analysis of a Continuing Care Intervention
for Cocaine Dependent Adults.” Presented at the International
Health Economics Association World Congress, Milan, Italy, July 15,
2015.
“Economic Analysis of Recovery Management Checkups for Women
Offenders (RMC-WO).” Presented at the Addiction Health Services
Research Annual Meeting, Boston, MA, October 16, 2014.
-
Kathryn E. McCollister Ph.D.
23
“Longitudinal Analyses of the Societal Costs of Criminal
Activity in an Aging Cohort of Minority Baby Boomers.” Presented at
the International Health Economics Association and European
Conference on Health Economics Joint Congress, Dublin, Ireland,
July 14, 2014.
“The Economic Burden of Disease by Industrial Sector:
Differences in Quality-Adjusted Life Years and Associated Costs.”
Poster presentation at the 2013 American Public Health Association
(APHA) Annual Meeting, Boston, Massachusetts, November 3, 2013.
“Informal Work and Problem Behavior among Middle School and High
School Students.” Presented at the Addiction Health Services
Research Annual Research Conference, Portland, Oregon, October 24,
2013.
“Work Experience and Sexual Behavior among Adolescents.”
Presented at the International Health Economics Association (iHEA)
World Congress, Sydney, Australia, July 9, 2013.
“The Economic Consequences of Substance Use Disorders: Monetary
Conversion Factors for Economic Evaluation and Policy Analysis.”
Presented at the Addiction Health Services Research Conference, New
York, October 2012.
“Cost−effectiveness Analysis of a Family−based Drug Use and HIV
Preventive Intervention Targeting Hispanic Juvenile, Offenders.”
Presented at the Addiction Health Services Research Conference, New
York, October 2012.
“Cost−effectiveness Analysis of Recovery Management Checkups for
Adults with Substance Use Disorders.” Presented at the Addiction
Health Services Research Conference, New York, October 2012.
“Economic Analyses of Recovery Management Checkups (RMCs) for
Substance Use Disorders.” Presented at the Western Economic
Association International (WEAI) Annual Meeting, San Francisco,
California, June 30, 2012.
“Cost−Effectiveness Analysis of Recovery Management Checkups
(RMCs) for Adults with Substance Use Disorders.” Presented at the
4th Biennial Conference of the American Society of Health
Economists (ASHEcon), Minneapolis, Minnesota, June 11, 2012.
“Informal Work and Sexual Behavior among Young Adults.” Poster
presentation at the 2011 American Public Health Association Annual
Meeting, Washington, DC, October 30, 2011.
“Main Findings from the Florida Cost Analysis of Addiction
Programs (FCAAP).” Presented at the Addiction Health Services
Research Annual Meeting, Fairfax, Virginia. October 5, 2011.
“Demand for Substance Abuse Treatment among Low−Income Adults:
Price Sensitivity and Other Barriers.” Poster presentation at the
2011 International Health Economics Association World Congress,
Toronto, Ontario (Canada), July 10, 2011.
“Price−Elasticity of Demand for Substance Abuse Treatment among
a Sample of Low−Income Adults.” Presented at the Addiction Health
Services Research Annual Meeting, Lexington, KY, October 27,
2010.
“Informal Work, Substance Use, and Delinquency among Young
Adults.” Poster presentation at the Addiction Health Services
Research Annual Meeting, Lexington, KY, October 26, 2010.
“Estimating the Economic Cost of Underage Drinking in Florida.”
Presented at the Addiction Health Services Research Annual Meeting
in Boston, MA, October 22, 2008.
-
Kathryn E. McCollister Ph.D.
24
“The Cost of Addiction Treatment from the Client’s Perspective:
Results from the Client Drug Abuse Treatment Cost Analysis
Program.” Presented at the Second Biennial Conference of the
American Society of Health Economists (ASHE), Durham, NC, June 23,
2008.
“Estimating the Costs of Post−release Interventions for Criminal
Offenders with Substance Use Disorder: Findings from Two CJ−DATS
Studies.” Presented at the Addiction Health Services Research
Annual Meeting, Athens, GA, October 17, 2007.
“New Perspectives in Estimating the Costs of Substance Abuse
Treatment using the Drug Abuse Treatment Cost Analysis Program
(DATCAP): The Client DATCAP and Caretaker DATCAP.” Presented at the
2007 International Health Economics Association World Congress,
Copenhagen, Denmark, July 11, 2007.
“Estimating the Differential Costs of Criminal Activity among
Juvenile Drug Court Participant Challenges and Recommendations.”
Presented at the 2007 Joint Meeting on Adolescent Treatment
Effectiveness (JMATE), Washington, D.C., April 26, 2007.
“The Cost of Addiction Treatment from the Client’s Perspective:
Results from the Client Drug Abuse Treatment Cost Analysis Program
(Client DATCAP).” Presented at the Addiction Health Services
Research Annual Meeting in Little Rock, AR, October 25, 2006.
“Juvenile Drug Court and the Economic Costs Associated with
Reduced Criminal Activity for Adolescent Substance Users.”
Presented at the Addiction Health Services Research Annual Meeting,
Little Rock, AR, October 25, 2006.
“Cost Utility in Drug Abuse Treatment Evaluation.” Discussant at
the First Inaugural Conference of the American Society of Health
Economists, Madison, WI, June 5, 2006.
“Estimating the Caretaker Costs of Adolescent Addiction
Treatment: Introducing the Caretaker Drug Abuse Treatment Cost
Analysis Program (Caretaker DATCAP).” Presented at the 2006 Joint
Meeting on Adolescent Treatment Effectiveness, Baltimore, MD, March
27, 2006.
“Long−term Cost Effectiveness of Addiction Treatment for
Criminal Offenders: Evaluating Treatment History and
Reincarceration 5 Years Post−parole.” Presented at the American
Public Health Association Annual Meeting in Washington, DC,
November 9, 2004
“The Cost of Crime to Society: New Crime−Specific Estimates for
Policy and Program Evaluation.” Presented at the Addiction Health
Services Research Annual Meeting, Philadelphia, PA, October 7,
2004.
“Post−Release Substance Abuse Treatment for Criminal Offenders:
A Cost−Effectiveness
Analysis.” Presented at the American Public Health Association
Annual Meeting, Philadelphia, PA, November 12, 2002.
“Post−Release Substance Abuse Treatment for Criminal Offenders:
A Cost−Effectiveness Analysis.” Presented at the Addiction Health
Services Research Annual Meeting, Key Largo, FL, October 30 –
November 1, 2002.
-
Kathryn E. McCollister Ph.D.
25
“Is In−Prison Treatment Enough? A Cost−Effectiveness Analysis of
Prison−Based Treatment and Aftercare Services for Substance Abusing
Offenders.” Presented at the American Public Health Administration
Annual Meeting, Atlanta, GA, October 24, 2001.
“Re−examining the Social Cost of Drug−Related Crime: Chronic
Drug Users as Perpetrators
and Victims.” Presented at the American Public Health
Administration Annual Meeting, Boston, MA, November 13, 2000.
“Re−examining the Social Cost of Drug−Related Crime: Chronic
Drug Users as Perpetrators and Victims.” Presented at the Western
Economic Association Annual Conference, Vancouver, British
Columbia, June 30, 2000.
“Benefit−Cost Analysis of a Modified Therapeutic Community for
Mentally Ill Chemical Abusers.” Presented at the MISA: Multiple
Disorders, Multiple Perspectives Conference, sponsored by MCP
Hahnemann University, Philadelphia, PA, April 28−30, 1999.
Other invited presentations:
“Health Economic Research Supporting the U.S. Response to the
Opioid Crisis: Defining Cost Effective Interventions and
Implementation Strategies,” Virtual Grand Rounds, Prevention
Science and Methodology Group (PSMG), November 19, 2019.
“Economics of Continuing Care for Substance Use Disorders.”
Grand Rounds Presentation, Weill Cornell Medicine, September 19,
2017.
“Methods and Data Sources for Measuring Comprehensive Disease
and Disability Burden Using HRQL Metrics.” Presented at the
National Institute on Occupational Safety and Health Workshop on
Measuring the Economic Burden of Disease and Disability among U.S.
Workers. Washington, DC, June 21, 2012.
“Juvenile Drug Court and the Economic Costs Associated with
Reduced Criminal Activity for Adolescent Substance Users.”
Presented at the NIDA Annual Advisory Board Meeting for Grant No.
R01 DA018645, Miami, FL, November 8, 2006.
“Methods and Challenges in Conducting Economic Evaluations of
Drug Court Interventions.” Invited presentation at the NIDA
Symposium on Drug Court and Other Problem Solving Courts: State of
the Science, Bethesda, MD, September 12, 2006.
“Estimating the Cost of Crime to Society: New Crime Specific
Estimates for Policy and Program Evaluation.” Presented at the
NIAAA Advisory Board Annual Meeting, Grant No. R01 AA13167, Miami
Beach, FL, April 7, 2005.
“Economic Evaluation of Substance Abuse Treatment in Criminal
Justice Settings.” Presented at NIDA’s CJ−DATS Steering Committee
Meeting, Bethesda, MD, April 4, 2005.
“Economic Evaluation of Addiction Treatment for Criminal
Offenders: Review of Recent Cost−Effectiveness Analyses.” Presented
at the Substance Abuse Treatment and Corrections: Prison−based
Treatment and Aftercare Teleconference organized by the Robert Wood
Johnson Foundation and the Office of State Legislatures, March 25,
2004.
“A Cost−Effectiveness Analysis of the Amity In−Prison TC and
Vista Aftercare Programs, Preliminary Results.” Presented at the
University of California, Los Angeles, Drug Abuse Research Center,
February 6, 2001.
-
Kathryn E. McCollister Ph.D.
26
“Benefit−Cost Analysis of a Modified Therapeutic Community for
Mentally Ill Chemical Abusers.” Presented at the Health
Administration Program/Department of Epidemiology and Public Health
Joint Seminar Series, University of Miami, Miami, FL, October 20,
1999.
“Economic Evaluation of Substance Abuse Programs in Criminal
Justice Settings.” Presented at the Policy Advisory Committee
Meeting for the Office of Substance Abuse Programs, California
Department of Corrections, San Diego, CA, August 19−20, 1999.
“Modeling the Political Economy of Sovereign Debt.” Presented at
the International/Development Economics Seminar Workshop Series at
Florida International University, Miami, Florida, April 14,
1999.
“Benefit−Cost Analysis of a Modified Therapeutic Community for
Mentally Ill Chemical Abusers.” Presented at the NIDA Advisory
Board Meeting, Grant R01 DA11506, University of Miami, Miami, FL,
April 8, 1999.
-
Kathryn E. McCollister Ph.D.
27
VI. TEACHING
25. Teaching Awards Received: N/A
26. Teaching Specialization
Teach two graduate health economics courses covering standard
economic theory and principles as well as economic evaluation of
behavioral health care interventions; cost- effectiveness,
benefit-cost, and cost-utility analyses; and health-related quality
of life. Course evaluations have been consistently very good (on
average 4.6 out of 5.0 since 2002).
Courses Taught
Health Economics for Evaluation and Policy (EPH−650)
2002 –Present
University of Miami, Department of Public Health Sciences
Health Economics and Financing (MD/MPH program; EPH-655)
University of Miami, Department of Public Health Sciences
2015 -Present
Microeconomic Theory (Undergraduate) Florida International
University, Department of Economics
1995 – 1999
Economic Growth (Graduate lab) Florida International University,
Department of Economics
1996 – 1998
Macroeconomic Theory (Graduate lab) Florida International
University, Department of Economics
1996 – 1998
University of Miami Invited Guest Lectureships
Global Health and Global Justice (EPH 616) 2018-Present
Introduction to Disease Prevention and Health Promotions
(EPH−614) 2011−2017
Health Policy (EPH-652) 2013-2017
Program Evaluation (EPH-644) 2014-2016
Introduction to Public Health (EPH 600) 2016-2017
Epidemiology of Drug Abuse (EPH−590) 2006 − 2010
27. Thesis and Dissertation Advisor/Post−doctoral Student
Supervision
Doctor of Philosophy in Epidemiology
Tyler S. Bartholomew, Ph.D. ABD. “Title Pending.” Member of
dissertation committee. Department of Public Health Sciences,
University of Miami Miller School of Medicine (2019 – present).
-
Kathryn E. McCollister Ph.D.
28
Diane Zheng, M.S., Ph.D. “Health Disparities in Visually
Impaired Adults with Multi-morbidity.” Member of dissertation
committee. Department of Public Health Sciences, University of
Miami Miller School of Medicine (2016 – 2019).
Claudia Uribe, M.D., Ph.D. “The Effects of Bariatric Surgery on
Medication and Health Services Utilization among Members from a
Large Health Benefits Company.” Member of dissertation committee.
Department of Epidemiology and Public Health, University of Miami
Miller School of Medicine (2009 to 2011).
Alberto Caban−Martinez, D.O., Ph.D., MPH. “Musculoskeletal
Disorders and Health Behaviors among US Adults.” Member of
dissertation committee. Department of Epidemiology and Public
Health, University of Miami Miller School of Medicine (2008 to
2010).
Eddy Perez, M.D., Ph.D. “An Enhanced Ecological Model
Population−Based Approach to Reduce Health Disparities and Achieve
Equity, Solidarity, and Gender Sensitivity for the Population
Living in Southwestern Bateyes of the Dominican Republic.” Member
of dissertation committee. Department of Epidemiology and Public
Health, University of Miami Miller School of Medicine (2007 to
2009).
Daniel Impoinvil, Ph.D. “Epidemiological and Economic Analysis
of Larval Control for the Reduction of Human−vector Contact in
Urban and Rural Kenya.” Member of dissertation committee.
Department of Epidemiology and Public Health, University of Miami
Miller School of Medicine (2004 to 2006).
Master of Public Health/Master of Science in Public Health
Derek M. Freitas, B.S., MSPH. “Informal and Formal Work
Experience and Sexual Behavior among Adolescents: Results from a
Nationally−Representative Survey.” Advisor and member of thesis
committee for MSPH. Department of Epidemiology and Public Health,
University of Miami Miller School of Medicine (2011 to 2012).
Kristen S. Laengle, MPH. “Prevalence of Overweight among Haitian
Immigrant Children and Adolescents.” Advisor and member of thesis
committee for MPH. Department of Epidemiology and Public Health,
University of Miami Miller School of Medicine (2004 to 2006).
VII. SERVICE
28. Academic Service
Director, Division of Health Services Research and Policy,
Department 2016 - Present of Public Health Sciences
Capstone advisor to MPH/MDMPH students 2014-Present
Faculty judge for the Eastern Atlantic Student Research Forum
2012–Present
Member of the University of Miami Faculty Senate, Constituency A
2011–2018
Member of the Graduate Faculty 2002–Present
Member of DPHS Admissions Committee for the MPH, MSPH
2012−2016
-
Kathryn E. McCollister Ph.D.
29
Member of the Prevention Science and Community Health PhD 2015
Admissions Committee
Member of the DPHS Recruitment Committee 2003–2011
Participant as Group Preceptor for the first year medical
Students’ journal club –Epi−ID module 2004 –2008
Member of the DPHS Curriculum/Admissions Committee for the MPH,
MSPH 2008 – 2009
Chairperson of the DPHS Admissions Committee for the MPH, MSPH,
and Ph.D. programs 2004 – 2008
Member of the DPHS Graduate Executive Policy Committee 2004 –
2008
29. Professional Service
Provide content for professional webinars and podcasts:
1. “Cost Effectiveness of Substance Abuse Treatment in Criminal
Justice Settings.” Knowledge Asset Web site created by the Robert
Wood Johnson Foundation's Substance Abuse Policy Research Program;
July 2008.
http://saprp.org/knowledgeassets/knowledge_detail.cfm?KAID=10
2. “Estimating Victim Costs of Crime for Cost−benefit Analyses
in Criminal Justice.” VERA Institute for Justice. Cost−benefit
Knowledge Bank Webinar on Demystifying Crime Victim Costs (with T.
Stanford and V. Levshin). 2012. VERA Victim Costs Webinar
3. “Economic Evaluation of The Juvenile Drug Court Reclaiming
Futures Model.” University of Arizona, Southwest Institute for
Research on Women (SIROW). 2016.
https://arizona.hosted.panopto.com/Panopto/Pages/Viewer.aspx?id=525d2c2b-5680-46c2-
b179-800cfbe41bd9
Serve on panels at professional conferences as the expert in
economic evaluation of addiction treatment and related
interventions:
1. “Economic Evaluation of SBIRT: Understanding the Return on
Investment Using Cost- Effectiveness and Benefit-Cost Analyses.”
Center for Substance Abuse Treatment, Substance Abuse and Mental
Health Services Administration, the Screening, Brief Intervention,
and Referral to Treatment (SBIRT), Virtual Grantee Meeting,
2014.
2. “Benefit-Cost Analysis of Juvenile Drug Court Reclaiming
Futures: Results from Five Sites.”
Presented as part of an expert panel on the JDC/RF model at the
Reclaiming Futures Annual Conference, hosted by the Robert Wood
Johnson Foundation and the JDC/RF National Program Office. April
2016.
30. Community Service
Member of the Hollywood Lakes Civic Association 2016 –
Present
http://saprp.org/knowledgeassets/knowledge_detail.cfm?KAID=10http://www.slideshare.net/CBKBank/110721-victim-costs-webinar-final-9595708https://arizona.hosted.panopto.com/Panopto/Pages/Viewer.aspx?id=525d2c2b-5680-46c2-b179-800cfbe41bd9https://arizona.hosted.panopto.com/Panopto/Pages/Viewer.aspx?id=525d2c2b-5680-46c2-b179-800cfbe41bd9https://arizona.hosted.panopto.com/Panopto/Pages/Viewer.aspx?id=525d2c2b-5680-46c2-b179-800cfbe41bd9
-
Kathryn E. McCollister Ph.D.
30
Member of the American Civil Liberties Union (ACLU) 2017 –
2018